We are live on
!
Find out more
CI
Clal Insurance Portfolio holdings
AUM
$16.6B
1-Year Est. Return
68.34%
This Fund
S&P 500
This Quarter
Est. Return
-5.27%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$7.29B
AUM Growth
-$228M
(-3%)
Cap. Flow
+$351M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
36.83%
Holding
180
New
8
Increased
35
Reduced
27
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SolarEdge
SEDG
|
+$114M |
| 2 |
Invesco Solar ETF
TAN
|
+$93.1M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$90.8M |
| 4 |
Enphase Energy
ENPH
|
+$67.6M |
| 5 |
Fortinet
FTNT
|
+$56.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$72.7M |
| 2 |
State Street SPDR S&P Metals & Mining ETF
XME
|
+$61.6M |
| 3 |
KLA
KLAC
|
+$52.9M |
| 4 |
ARK Innovation ETF
ARKK
|
+$48M |
| 5 |
ZIM Integrated Shipping Services
ZIM
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.16% |
| 2 | Materials | 7.26% |
| 3 | Industrials | 6.91% |
| 4 | Communication Services | 6.76% |
| 5 | Healthcare | 6.12% |
Similar funds
AIMCA
EIP
IG
BCIM
UCFA
VMPIC
LCOV
Clal Insurance's Q3 2022 Portfolio in Review
As of Q3 2022, Clal Insurance held 180 positions worth $7.29B, down 3% from $7.51B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Clal Insurance deployed $351M of net new capital in Q3 2022, opening 8 new positions and adding to 35 existing holdings. Its largest new stake was Applied Materials: 500,000 shares worth $41M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Materials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $72.7M trimmed.
- Clal Insurance's largest Q3 2022 buy was Applied Materials: 500,000 shares worth $41M.
- Clal Insurance added most to SolarEdge in Q3 2022, an estimated $114M increase.
- Clal Insurance's biggest Q3 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $72.7M.
- Clal Insurance fully exited ARK Innovation ETF in Q3 2022, selling an estimated $48M.
- Clal Insurance's ten largest holdings make up 37% of its $7.29B portfolio in Q3 2022.
- Clal Insurance opened 8 new positions and closed 12 in Q3 2022.
- Clal Insurance's portfolio value fell 3% quarter-over-quarter to $7.29B.
Based on Clal Insurance's 13F filing for Q3 2022, filed 14 Nov 2022.